PharmaCyte Biotech Inc (PMCB) Company Profile & Statistics

PharmaCyte Biotech Inc
PMCB
(Nasdaq - US)
Closed
1.70
-0.05 (-2.86%)
in:usd•As of: Nov 22, 2024 15:30 UTC -5
Open
1.68
High
1.70
Low
1.67

About PharmaCyte Biotech Inc

CEO

Joshua N. Silverman

Headquarters

3960 howard hughes parkway, suite 500

las vegas, nv 89169, united states

Auditor

Marcum LLP

Employees

Share Holders

1,400

Website

www.PharmaCyte.com

Industry

pharmaceuticals other

Sector

health technology

Company Overview

PharmaCyte Biotech, Inc. is a clinical stage biotechnology company. It is focused on developing and preparing to commercialize treatments for cancer and diabetes based upon a proprietary cellulose-based live cell encapsulation technology known as Cell-in-a-Box(R). The Company's patented technology is used in the treatment of several types of cancer, including advanced, inoperable pancreatic cancer and diabetes. PharmaCyte Biotech, Inc., formerly known as Nuvilex, Inc., is based in United States.

PharmaCyte Biotech Inc Statistics

Valuation Measures

Market Capitalization ²	13.06M
Enterprise Value	-19.58M
Enterprise Value/EBITDA (ttm)	2.54
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	0.30
Price to Sales (ttm)	N/A
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	0.00%
Operating Margin (ttm)	N/A
Profit Margin (ttm)	0.00%
Return on Equity (ttm)	1.38%
Return on Invested Capital (ttm)	59.58%
Return on Assets (ttm)	0.71%

Income Statement

Revenue (ttm)	0.00
Revenue Per Share (ttm)	0.00
Gross Profit (ttm)	0.00
EBITDA (ttm)³	-7.71M
Net Income Avi to Common (ttm)	4.50M
Diluted EPS (ttm)	0.66

Share Statistics

Beta (5Y Monthly)	-0.20
52-Week Change	-22.02%
S&P500 52-Week Change	31.00%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	7.68M
Dividend Yield	0.00%
Float ⁴	7.60M
% Held by Insiders	1.03%
% Held by Institutions	34.24%

Balance Sheet

Total Cash (mrq)	32.64M
Total Cash Per Share (mrq)	4.25
Total Debt (mrq)	0.00
Total Debt/Equity (mrq)	0.00%
Current Ratio (mrq)	4.40%
Quick Ratio (mrq)	4.40%
Book Value Per Share (mrq)	6.18

Cash Flow

Operating Cash Flow Per Share (ytd)	-0.05
Free Cash Flow (ytd)	-373.30K

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

PharmaCyte Biotech Inc

Trade With A Regulated Broker